Janux Therapeutics: Downgrading To 'Hold' Rating After Latest Updated Phase 1 JANX007 mCRPC Data

Janux Therapeutics' cash runway is about 12 months; dilution is likely, and upcoming data from both JANX007 and JANX008 are ...
The American Journal of Managed Care

Managing Cardio-Renal-Metabolic Diseases Requires Multifactorial Approach

Speakers at the Institute for Value-Based Medicine event held September 18, 2025, in Nyack, New York, spoke about methods of managing cardio-renal-metabolic disease.

Vera Therapeutics, Inc. (VERA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Citi Annual Global Healthcare Conference 2025 December 3, 2025 4:00 PM ESTCompany ParticipantsMarshall Fordyce - ...

Analysts Conflicted on These Energy Names: Greenfire Resources (GFR) and China Aviation Oil (Singapore) (OtherCAOLF)

Detailed price information for Greenfire Resources Ltd (GFR-N) from The Globe and Mail including charting and trades.

Taiho Oncology Europe announces the launch of Lytgobi® (futibatinib) in the United Kingdom for eligible adult patients with a previously treated subtype of locally adva…

Trade and Medical Media Only. Taiho Oncology Europe GmbH announced today the UK launch of Lytgobi ® (futibatinib), an ...